Toxoplasmosis of newborn
ICD-10 B68.1 is a billable code used to indicate a diagnosis of toxoplasmosis of newborn.
Toxoplasmosis of the newborn is a congenital infection caused by the parasite Toxoplasma gondii, which can be transmitted from an infected mother to her fetus during pregnancy. This condition is particularly concerning as it can lead to severe complications in the newborn, including neurological damage, chorioretinitis, and hydrocephalus. The severity of the disease can vary widely, with some infants showing no symptoms at birth while others may present with significant health issues. Diagnosis is typically made through serological testing for Toxoplasma antibodies or through imaging studies that reveal characteristic findings. Treatment often involves the use of antiparasitic medications such as pyrimethamine and sulfadiazine, which are aimed at reducing the parasitic load and preventing further complications. Early diagnosis and intervention are crucial for improving outcomes in affected infants.
Detailed clinical notes on symptoms, lab results, and treatment plans.
Newborns presenting with jaundice, seizures, or eye abnormalities.
Documentation must clearly indicate the timing of maternal infection and any treatment provided.
Complete maternal history, including serological testing results.
Pregnant women with known exposure to Toxoplasma or positive serology.
Accurate coding requires clear linkage between maternal and neonatal conditions.
Used to confirm diagnosis in newborns with suspected congenital toxoplasmosis.
Document the reason for testing and results.
Pediatricians should ensure that maternal history is included.
Common symptoms include chorioretinitis, hydrocephalus, intracranial calcifications, and jaundice. Some infants may be asymptomatic at birth.
